Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252)

Market Cap	16.68B
Revenue (ttm)	273.76M
Net Income (ttm)	-683.63M
Shares Out	1.01B
EPS (ttm)	-0.71
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,660,136
Average Volume	7,391,510
Open	17.00
Previous Close	17.46
Day's Range	16.22 - 17.60
52-Week Range	6.03 - 25.65
Beta	1.59
RSI	36.02
Earnings Date	Mar 28, 2025

About HKG:2252

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People’s Republic of China. The company offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot fo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 646
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2252

Financial Performance

In 2024, HKG:2252's revenue was 257.25 million, an increase of 145.95% compared to the previous year's 104.59 million. Losses were -642.41 million, -36.53% less than in 2023.

Financial numbers in CNY